Particle.news

Download on the App Store

Trump Halts Federal Funding for Gain-of-Function Research Abroad

The executive order targets high-risk biological studies in nations with insufficient oversight, citing lab-leak concerns tied to COVID-19 origins.

ANYANG, CHINA - SEPTEMBER 5, 2022 - Volunteers input test tube information for nucleic acid collection in a gas film laboratory for COVID-19 prevention and control in Anyang, Henan Province, China, Sept 5, 2022. (Photo credit should read CFOTO/Future Publishing via Getty Images)
Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. speaks as President Donald Trump (not pictured) signs executive orders and proclamations in the Oval Office at the White House, in Washington, D.C., on May 5, 2025.
The new executive order from President Donald Trump restricts federal funds from being used for the controversial research known as "Gain of Function" in countries where sufficient oversight is not possible, including the Wuhan Institute of Virology in Wuhan, China. (HECTOR RETAMAL/AFP file)

Overview

  • President Trump has signed an executive order banning present and future federal funding for gain-of-function research in countries of concern, including China and Iran.
  • The order empowers U.S. agencies like NIH to identify and terminate funding for research deemed a threat to public health or national security.
  • The White House asserts that a lab-related incident involving gain-of-function research is the most likely origin of COVID-19, reinforcing the need for stricter biosecurity policies.
  • The policy aims to prevent lab-related incidents while ensuring that legitimate biological research critical for pandemic preparedness continues unimpeded.
  • The order mandates the development of new safety standards and oversight mechanisms by federal agencies to govern high-risk biological research.